Professor Walter WillettAt the Limits - Leading Medical Education2026-09-22 | Professor Walter WillettDemystifying AI and embedding it into clinical practice - Dirk Smeets | AI in HealthcareAt the Limits - Leading Medical Education2024-02-29 | The full multimedia of selected presentations is available on Open Dialogue, med-ed hub from At the Limits.
https://opendialogue.health/
Featuring live webcasts, interviews, and presentations from a host of the world’s leading researchers, scientists and clinicians, the hub includes hundreds of hours of archive material alongside the newest and most recent content.Videos from the Sept. MS events are now online for HCPs on our Med Ed hub www.opendialogue.healthAt the Limits - Leading Medical Education2023-10-11 | ...Cardiology, Diabetes & Nephrology At the Limits 2023 | Available to view nowAt the Limits - Leading Medical Education2023-06-26 | The 2023 CDNATL event took place in April and all the multimedia is now available to view at www.opendialogue.healthProfessor Theresa McDonaghAt the Limits - Leading Medical Education2022-12-08 | Heart failure therapy – exciting times!Professor Peter LibbyAt the Limits - Leading Medical Education2022-12-07 | Inflammation/atherosclerosis: the knowns & the unknowns!Professor Carel le RouxAt the Limits - Leading Medical Education2022-12-06 | How the gut talks to the brain and protects the heart and kidneysDebate a new era in the management of type 2 diabetes & cardiorenal diseaseAt the Limits - Leading Medical Education2022-12-05 | Professor Mansoor Husain & Professor Niko Marx a new era in the management of type 2 diabetes & cardiorenal disease.Professor Aruna PradhanAt the Limits - Leading Medical Education2022-12-04 | Pre-diabetes – has the damage already commenced (is it too late)?Professor Jean Pierre DesprésAt the Limits - Leading Medical Education2022-12-03 | Lifestyle & obesity (or – let’s not forget the metabolic syndrome!)Professor Peter StenvinkelAt the Limits - Leading Medical Education2022-12-02 | CKD: accelerant of ageing-inflammation, vascular calcification, and renal functionProfessor Melanie DaviesAt the Limits - Leading Medical Education2022-12-01 | An update on the weight management – 12 months on!Professor Richard SchillingAt the Limits - Leading Medical Education2022-11-30 | Atrial fibrillation and the use of oral anticoagulant therapy – what we need to knowProfessor Stephanie BaldewegAt the Limits - Leading Medical Education2022-11-30 | Management of type 2 diabetes: out with the old, in with the new.Professor Alastair O’BrienAt the Limits - Leading Medical Education2022-11-30 | How much should I worry about NAFLD?Professor Simon GriffinAt the Limits - Leading Medical Education2022-11-30 | Personalised medicine – can it help my practice?Professor May NgAt the Limits - Leading Medical Education2022-11-30 | Management of children and adolescents with diabetes: what we need to knowDr Lucy MackillopAt the Limits - Leading Medical Education2022-11-29 | Diabetes and pregnancy: the challenges!Dr Ian PrenelleAt the Limits - Leading Medical Education2022-11-29 | Management of diabetes in those with severe mental illness: how do we improve their outcomes?Debate: Cognitive markers are more useful than biomarkers in MS monitoringAt the Limits - Leading Medical Education2022-10-12 | ...Professor Basil Sharrack and Professor John Snowden - AHSCT and the management of MSAt the Limits - Leading Medical Education2022-10-12 | AHSCT and the management of MSProfessor Sergio Baranzini - The genetic and other risk factors underlying MSAt the Limits - Leading Medical Education2022-10-12 | - The genetic and other risk factors underlying MS – what we know in 2022?Professor Klaus Schmierer - Pushing the envelope at both ends of the disease spectrumAt the Limits - Leading Medical Education2022-10-12 | Pushing the envelope at both ends of the disease spectrum – AttackMS & ChariotMSProfessor Jon Stone - Undiagnosing MS, including the accuracy of clinical diagnosisAt the Limits - Leading Medical Education2022-10-12 | Undiagnosing MS, including the accuracy of clinical diagnosisProfessor Jeremy Chataway - Octopus - inside the progressive MS mega-trialAt the Limits - Leading Medical Education2022-10-12 | Octopus - inside the progressive MS mega-trialProfessor Dr Lars Alfredsson - MS at the Limits 2022 - aetiology sessionAt the Limits - Leading Medical Education2022-10-12 | MS at the Limits 2022 - aetiology session - smoking and organic solventsDr Veronique Miron - Glial interactions driving remyelination in MSAt the Limits - Leading Medical Education2022-10-12 | Glial interactions driving remyelination in MSDr Ruth Dobson - How pregnant women with MS are treated in the UKAt the Limits - Leading Medical Education2022-10-12 | How pregnant women with MS are treated in the UK – lessons from the MS pregnancy registerDr Martina Absinta - Using paramagnetic rim lesions in proof-of-concept clinical trialsAt the Limits - Leading Medical Education2022-10-12 | Using paramagnetic rim lesions in proof-of-concept clinical trialsDr Maria Teresa Cencioni - B-cells in multiple sclerosis — from targeted depletion ...At the Limits - Leading Medical Education2022-10-12 | B-cells in multiple sclerosis — from targeted depletion to immune reconstitution therapiesDr Emma Tallantyre - DMT management – where disease biology and treatment algorithms meet (or not!)At the Limits - Leading Medical Education2022-10-12 | DMT management – where disease biology and treatment algorithms meet (or not!)Dr E Ann Yeh - Longer-term safety of B-cell therapies in MSAt the Limits - Leading Medical Education2022-10-12 | Longer-term safety of B-cell therapies in MSDr Benjamin Jacobs - Should we study MS genetics in diverse ancestries?At the Limits - Leading Medical Education2022-10-12 | Should we study MS genetics in diverse ancestries?Dr Amit Bar Or - Does ageing predict the cessation of MS?At the Limits - Leading Medical Education2022-10-12 | Does ageing predict the cessation of MS? (Immunology of MS in an ageing population / Clinical relapses)Ellie Garlick & Sarah Roderick - Thinking Ahead – Advance Care PlanningAt the Limits - Leading Medical Education2022-10-03 | ...Dr Azza Ismail & Daisy Cam - Obstetrics & MSAt the Limits - Leading Medical Education2022-10-03 | ...Dr David Paling - Recognising the signals of change that help raise awareness of SPMSAt the Limits - Leading Medical Education2022-10-03 | ...Dr Evangeline Wassmer - Demyelinating disorders and childhood MSAt the Limits - Leading Medical Education2022-10-03 | ...Dr Glenn Nielsen - Motor FND: recent advances and future directionsAt the Limits - Leading Medical Education2022-10-03 | ...Dr Julian Furby - DMTs in progressive MSAt the Limits - Leading Medical Education2022-10-03 | ...Dr Kate Petheram - Menopause & MSAt the Limits - Leading Medical Education2022-10-03 | ...Dr Lauren Krupp Neurology Interventions to tackle fatigue, cognitive problems associated with MSAt the Limits - Leading Medical Education2022-10-03 | ...Dr Martin Duddy - A review of current clinical trials in MSAt the Limits - Leading Medical Education2022-10-03 | ...Dr Orla Tuohy - DMTs and ageing MS patients – what the MS Nurse needs to knowAt the Limits - Leading Medical Education2022-10-03 | ...Miranda Olding - The value of nurse prescribing in the management of people with MSAt the Limits - Leading Medical Education2022-10-03 | ...Professor Stephen Sawcer - Genetic determinants of disease outcomeAt the Limits - Leading Medical Education2022-10-03 | ...Professor Chiara Bonini - Novel gene editing technology – the application of CRISPR - Pt. 1At the Limits - Leading Medical Education2022-07-11 | Professor Chiara Bonini - Novel gene editing technology – the application of CRISPR - Pt. 1Professor Malcolm K Brenner - Overview of cell therapy for cancer in 2022 and beyondAt the Limits - Leading Medical Education2022-07-11 | Professor Malcolm K Brenner - Overview of cell therapy for cancer in 2022 and beyondDr Marcel R. M. van den Brink - Can microbiota influence CAR-T safety and efficacy?At the Limits - Leading Medical Education2022-07-11 | Dr Marcel R. M. van den Brink - Can microbiota influence CAR-T safety and efficacy?Dr Renier J Brentjens - New CAR-T therapiesAt the Limits - Leading Medical Education2022-07-11 | Dr Renier J Brentjens - New CAR-T therapiesDr Tanya Siddiqi - Combination therapies in Lymphoma and CLLAt the Limits - Leading Medical Education2022-07-11 | Dr Tanya Siddiqi - Combination therapies in Lymphoma and CLL